Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ Press Release Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…CertaraOctober 6, 2016
Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Publication Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models CertaraOctober 5, 2016
A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Publication A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…CertaraOctober 1, 2016
Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Publication Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains CertaraOctober 1, 2016
FDA’s New Module 1 is a Bridge to eCTD 4 Blog FDA’s New Module 1 is a Bridge to eCTD 4 Editor’s note: Jason Rock served as Project Lead for the HL7 RCRIM Expert Working Group…CertaraSeptember 13, 2016
Arming Adherence-based Drug Development with Pharmacometrics Blog Arming Adherence-based Drug Development with Pharmacometrics The time is right to explore how sensor-enabled digital adherence monitoring systems can benefit patients,…CertaraSeptember 12, 2016
Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists Brochure Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists Phoenix NLME is the PK/PD modeling software that is user-friendly and easy-to-learn. Built from the…CertaraSeptember 12, 2016
The Role of a U.S. Agent Blog The Role of a U.S. Agent Foreign sponsors of drug applications who want to conduct business in the United States need…CertaraSeptember 6, 2016
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB Publication Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB CertaraAugust 10, 2016
Rare Disease and Orphan Drug Development Brochure Rare Disease and Orphan Drug Development There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…CertaraAugust 3, 2016